Royce & Associates LP Reduces Stock Position in Travere Therapeutics, Inc. $TVTX

robot
Abstract generation in progress

Royce & Associates LP significantly reduced its stake in Travere Therapeutics, Inc. (NASDAQ:TVTX) by 67.7% in the third quarter, selling 257,747 shares and holding 123,250 shares valued at $2.95 million. Other institutional investors like Arizona State Retirement System and Prudential Financial Inc. also adjusted their holdings. The article also notes recent insider sales by Peter Heerma and Christopher R. Cline, Travere Therapeutics’ stock performance, and recent analyst ratings.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin